- Home
- Publications
- Publication Search
- Publication Details
Title
Osteosarcoma: Accelerating Progress Makes for a Hopeful Future
Authors
Keywords
-
Journal
Frontiers in Oncology
Volume 8, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2018-01-26
DOI
10.3389/fonc.2018.00004
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Temporal Trends in Treatment and Subsequent Neoplasm Risk Among 5-Year Survivors of Childhood Cancer, 1970-2015
- (2017) Lucie M. Turcotte et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Annual Report to the Nation on the Status of Cancer, 1975–2014, Featuring Survival
- (2017) Ahmedin Jemal et al. JNCI-Journal of the National Cancer Institute
- Pembrolizumab in advanced soft-tissue sarcoma and bone sarcoma (SARC028): a multicentre, two-cohort, single-arm, open-label, phase 2 trial
- (2017) Hussein A Tawbi et al. LANCET ONCOLOGY
- Targeting programmed cell death ligand 1 by CRISPR/Cas9 in osteosarcoma cells
- (2017) Yunfei Liao et al. Oncotarget
- Annual Report to the Nation on the Status of Cancer, 1975–2014, Featuring Survival
- (2017) Ahmedin Jemal et al. JNCI-Journal of the National Cancer Institute
- Comparative proteomic investigation of metastatic and non-metastatic osteosarcoma cells of human and canine origin
- (2017) Jahnabi Roy et al. PLoS One
- Osteosarcoma enters a post genomic era with in silico opportunities: Generation of the High Dimensional Database for facilitating sarcoma biology research: A report from the Children's Oncology Group and the QuadW Foundation
- (2017) Jason Glover et al. PLoS One
- Abstract B40: Autocrine and paracrine IL-6 and IL-8 drive osteosarcoma lung tropism and facilitate metastasis
- (2016) Ryan D. Roberts et al. CANCER RESEARCH
- Np63 Silences a miRNA Program to Aberrantly Initiate a Wound-Healing Program That Promotes TGF -Induced Metastasis
- (2016) L. Rodriguez Calleja et al. CANCER RESEARCH
- mTOR Inhibition Mitigates Enhanced mRNA Translation Associated with the Metastatic Phenotype of Osteosarcoma Cells In Vivo
- (2016) J. J. Morrow et al. CLINICAL CANCER RESEARCH
- Ezrin Inhibition Up-regulates Stress Response Gene Expression
- (2016) Haydar Çelik et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Comparison of MAPIE versus MAP in patients with a poor response to preoperative chemotherapy for newly diagnosed high-grade osteosarcoma (EURAMOS-1): an open-label, international, randomised controlled trial
- (2016) Neyssa M Marina et al. LANCET ONCOLOGY
- Reduction in Late Mortality among 5-Year Survivors of Childhood Cancer
- (2016) Gregory T. Armstrong et al. NEW ENGLAND JOURNAL OF MEDICINE
- Tumor-Activated Mesenchymal Stromal Cells Promote Osteosarcoma Stemness and Migratory Potential via IL-6 Secretion
- (2016) Margherita Cortini et al. PLoS One
- Perspectives from man’s best friend: National Academy of Medicine’s Workshop on Comparative Oncology
- (2016) Amy K. LeBlanc et al. Science Translational Medicine
- A monoclonal antibody against the Wnt signaling inhibitor dickkopf-1 inhibits osteosarcoma metastasis in a preclinical model
- (2016) Seth D. Goldstein et al. Oncotarget
- ΔNp63 mediates cellular survival and metastasis in canine osteosarcoma
- (2016) Maren Cam et al. Oncotarget
- Upregulation of Glucose-Regulated Protein 78 in Metastatic Cancer Cells Is Necessary for Lung Metastasis Progression
- (2016) Michael M. Lizardo et al. NEOPLASIA
- Immune infiltration and PD-L1 expression in the tumor microenvironment are prognostic in osteosarcoma
- (2016) Pratistha Koirala et al. Scientific Reports
- Systematic Screening Identifies Dual PI3K and mTOR Inhibition as a Conserved Therapeutic Vulnerability in Osteosarcoma
- (2015) A. Gupte et al. CLINICAL CANCER RESEARCH
- Phase I Clinical Trial of Ipilimumab in Pediatric Patients with Advanced Solid Tumors
- (2015) M. S. Merchant et al. CLINICAL CANCER RESEARCH
- Methotrexate, Doxorubicin, and Cisplatin (MAP) Plus Maintenance Pegylated Interferon Alfa-2b Versus MAP Alone in Patients With Resectable High-Grade Osteosarcoma and Good Histologic Response to Preoperative MAP: First Results of the EURAMOS-1 Good Response Randomized Controlled Trial
- (2015) Stefan S. Bielack et al. JOURNAL OF CLINICAL ONCOLOGY
- The Immunotherapy of Canine Osteosarcoma: A Historical and Systematic Review
- (2015) K.L. Wycislo et al. JOURNAL OF VETERINARY INTERNAL MEDICINE
- A Sleeping Beauty forward genetic screen identifies new genes and pathways driving osteosarcoma development and metastasis
- (2015) Branden S Moriarity et al. NATURE GENETICS
- High-throughput screening using patient-derived tumor xenografts to predict clinical trial drug response
- (2015) Hui Gao et al. NATURE MEDICINE
- NKD2, a negative regulator of Wnt signaling, suppresses tumor growth and metastasis in osteosarcoma
- (2015) S Zhao et al. ONCOGENE
- RANKL blockade prevents and treats aggressive osteosarcomas
- (2015) Yan Chen et al. Science Translational Medicine
- Exome sequencing of osteosarcoma reveals mutation signatures reminiscent of BRCA deficiency
- (2015) Michal Kovac et al. Nature Communications
- Combination immunotherapy with α-CTLA-4 and α-PD-L1 antibody blockade prevents immune escape and leads to complete control of metastatic osteosarcoma
- (2015) Danielle M Lussier et al. Journal for ImmunoTherapy of Cancer
- Apoptosis Resistance and PKC Signaling: Distinguishing Features of High and Low Metastatic Cells
- (2015) Sung-Hyeok Hong et al. NEOPLASIA
- Toward a Drug Development Path That Targets Metastatic Progression in Osteosarcoma
- (2014) C. Khanna et al. CLINICAL CANCER RESEARCH
- Canine Osteosarcoma: A Naturally Occurring Disease to Inform Pediatric Oncology
- (2014) J. M. Fenger et al. ILAR JOURNAL
- MLN0128, an ATP-Competitive mTOR Kinase Inhibitor with Potent In Vitro and In Vivo Antitumor Activity, as Potential Therapy for Bone and Soft-Tissue Sarcoma
- (2014) E. K. Slotkin et al. MOLECULAR CANCER THERAPEUTICS
- A summary of the osteosarcoma banking efforts: A report from the Children's Oncology Group and the QuadW Foundation
- (2014) Jason Glover et al. PEDIATRIC BLOOD & CANCER
- Complementary genomic approaches highlight the PI3K/mTOR pathway as a common vulnerability in osteosarcoma
- (2014) Jennifer A. Perry et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Patient-Derived Xenograft Models: An Emerging Platform for Translational Cancer Research
- (2014) M. Hidalgo et al. Cancer Discovery
- Recurrent Somatic Structural Variations Contribute to Tumorigenesis in Pediatric Osteosarcoma
- (2014) Xiang Chen et al. Cell Reports
- Animal Models in Osteosarcoma
- (2014) Maria V. Guijarro et al. Frontiers in Oncology
- Np63 Promotes Pediatric Neuroblastoma and Osteosarcoma by Regulating Tumor Angiogenesis
- (2013) H. K. Bid et al. CANCER RESEARCH
- High-dose chemotherapy with stem cell rescue in the primary treatment of metastatic and pelvic osteosarcoma: Final results of the ISG/SSG II study
- (2013) Kjetil Boye et al. PEDIATRIC BLOOD & CANCER
- Characterization of a Large Panel of Patient-Derived Tumor Xenografts Representing the Clinical Heterogeneity of Human Colorectal Cancer
- (2012) S. Julien et al. CLINICAL CANCER RESEARCH
- Patient-derived tumour xenografts as models for oncology drug development
- (2012) John J. Tentler et al. Nature Reviews Clinical Oncology
- A genome-wide approach to comparative oncology: high-resolution oligonucleotide aCGH of canine and human osteosarcoma pinpoints shared microaberrations
- (2012) Andrea Y. Angstadt et al. Cancer Genetics
- Molecular subtypes of osteosarcoma identified by reducing tumor heterogeneity through an interspecies comparative approach
- (2011) Milcah C. Scott et al. BONE
- Functional characterization of osteosarcoma cell lines provides representative models to study the human disease
- (2011) Alexander B Mohseny et al. LABORATORY INVESTIGATION
- Small molecule inhibitors of ezrin inhibit the invasive phenotype of osteosarcoma cells
- (2011) G Bulut et al. ONCOGENE
- Redefining the relevance of established cancer cell lines to the study of mechanisms of clinical anti-cancer drug resistance
- (2011) J.-P. Gillet et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Prkar1a is an osteosarcoma tumor suppressor that defines a molecular subclass in mice
- (2010) Sam D. Molyneux et al. JOURNAL OF CLINICAL INVESTIGATION
- R1507, a fully human monoclonal antibody targeting IGF-1R, is effective alone and in combination with rapamycin in inhibiting growth of osteosarcoma xenografts
- (2010) E. Anders Kolb et al. PEDIATRIC BLOOD & CANCER
- Osteosarcoma in adolescents and adults: survival analysis with and without lung metastases
- (2009) A. H. Aljubran et al. ANNALS OF ONCOLOGY
- Canine tumor cross-species genomics uncovers targets linked to osteosarcoma progression
- (2009) Melissa Paoloni et al. BMC GENOMICS
- The Comparative Oncology Trials Consortium: Using Spontaneously Occurring Cancers in Dogs to Inform the Cancer Drug Development Pathway
- (2009) Ira Gordon et al. PLOS MEDICINE
- Critical Role of Notch Signaling in Osteosarcoma Invasion and Metastasis
- (2008) P. Zhang et al. CLINICAL CANCER RESEARCH
- Conditional mouse osteosarcoma, dependent on p53 loss and potentiated by loss of Rb, mimics the human disease
- (2008) C. R. Walkley et al. GENES & DEVELOPMENT
- Osteosarcoma: The Addition of Muramyl Tripeptide to Chemotherapy Improves Overall Survival—A Report From the Children's Oncology Group
- (2008) Paul A. Meyers et al. JOURNAL OF CLINICAL ONCOLOGY
- Wnt10b induces chemotaxis of osteosarcoma and correlates with reduced survival
- (2008) Kevin Chen et al. PEDIATRIC BLOOD & CANCER
- Metastatic osteosarcoma induced by inactivation of Rb and p53 in the osteoblast lineage
- (2008) S. D. Berman et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More